Crexendo (CXDO) COO exercises 10,000 options, sells 10,000 at $7.174

Crexendo (CXDO) Form 4: Chief Operating Officer Douglas Walter Gaylor exercised 10,000 stock options at $2.25 and sold 10,000 common shares at a weighted average price of $7.174.

Rhea-AI Filing Summary

Crexendo (CXDO) Form 4: Chief Operating Officer Douglas Walter Gaylor exercised 10,000 stock options at $2.25 and sold 10,000 common shares at a weighted average price of $7.174. Following these transactions, he directly beneficially owned 243,135 common shares and held 22,000 derivative securities (options) after the exercise.

The sale was made under a Rule 10b5-1(c) trading plan entered on December 11, 2024. The options exercised relate to grants that vested over 36 equal monthly installments beginning on March 12, 2019, and carry a stated expiration of February 12, 2026.

Insider Trade Summary

Exercise and Sale: 10,000 shares ($49K approx. pre-tax spread)

Exercise and Sale 3 txns

Insider Gaylor Douglas Walter

Role Chief Operating Officer

Sold 10,000 shs ($72K)

Approx. gross sale proceeds $72K

Approx. exercise cost $23K

Approx. pre-tax spread $49K

Type	Security	Shares	Price	Value
Exercise	Stock Options	10,000	$2.25	$23K
Sale	Common stock	10,000	$7.174	$72K
Exercise	Common Stock	10,000	$2.25	$23K

Holdings After Transaction: Stock Options — 22,000 contracts (Direct); Common stock — 243,135 shares (Direct)

Footnotes (3)

1. F1. This sale was made pursuant to a plan intended to comply with Rule 10b5-1(c), previously entered into on December 11, 2024, at which time Mr. Gaylor was not aware of material nonpublic information.
2. F2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.15 to $7.19. Details can be provided upon request.
3. F3. The stock options vested over 36 equal monthly installments beginning on 3/12/2019.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did CXDO's COO report on Form 4?

He exercised 10,000 stock options at $2.25 and sold 10,000 shares at a $7.174 weighted average price.

When did the transactions occur for CXDO?

The option exercise is listed on 11/07/2025 (Table I) and also shown in Table II on 11/10/2025; the share sale occurred on 11/10/2025.

How many CXDO shares does the reporting person own after the transactions?

He directly beneficially owned 243,135 common shares after the reported transactions.

What is the status of the reporting person's remaining options?

He held 22,000 derivative securities (options) after the exercise; the options have a stated expiration of 02/12/2026.

Was the sale under a 10b5-1 plan for CXDO?

Yes. The sale was made pursuant to a Rule 10b5-1(c) plan entered on December 11, 2024.

What price range were the CXDO shares sold at?

The weighted average sale price was $7.174, with individual trades ranging from $7.15 to $7.19.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/12/2025 - 01:26 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gaylor Douglas Walter

(Last) (First) (Middle)

1225 W WASHINGTON ST

SUITE 213

(Street)

TEMPE AZ 85288

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Crexendo, Inc. [ CXDO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Operating Officer

3. Date of Earliest Transaction (Month/Day/Year)
11/07/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/07/2025		M		10,000	A	$2.25	253,135	D
Common stock	11/10/2025		S(1)		10,000	D	$7.174(2)	243,135	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options	$2.25	11/10/2025		M			10,000	(3)	02/12/2026	Common Stock	10,000	$2.25	22,000	D

Explanation of Responses:

1. This sale was made pursuant to a plan intended to comply with Rule 10b5-1(c), previously entered into on December 11, 2024, at which time Mr. Gaylor was not aware of material nonpublic information.

2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.15 to $7.19. Details can be provided upon request.

3. The stock options vested over 36 equal monthly installments beginning on 3/12/2019.

	/s/Douglas Walter Gaylor	11/12/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.